| CCND2 rearrangements are the most frequent genetic events in cyclin D1− mantle cell lymphoma I Salaverria, C Royo, A Carvajal-Cuenca, G Clot, A Navarro, A Valera, ... Blood, The Journal of the American Society of Hematology 121 (8), 1394-1402, 2013 | 228 | 2013 |
| Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation SA Stewart, B Poon, JY Song, ISY Chen Journal of virology 74 (7), 3105-3111, 2000 | 211 | 2000 |
| In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior A Carvajal-Cuenca, LF Sua, NM Silva, S Pittaluga, C Royo, JY Song, ... Haematologica 97 (2), 270, 2012 | 191 | 2012 |
| Relapsed or refractory double-expressor and double-hit lymphomas have inferior progression-free survival after autologous stem-cell transplantation AF Herrera, M Mei, L Low, HT Kim, GK Griffin, JY Song, RW Merryman, ... Journal of Clinical Oncology 35 (1), 24, 2017 | 177 | 2017 |
| Remissions of acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm following treatment with CD123-specific CAR T cells: a first-in-human clinical trial L Budde, JY Song, Y Kim, S Blanchard, J Wagner, AS Stein, L Weng, ... Blood 130, 811, 2017 | 155 | 2017 |
| Lymphomatoid granulomatosis—a single institute experience: pathologic findings and clinical correlations JY Song, S Pittaluga, K Dunleavy, N Grant, T White, L Jiang, T Davies-Hill, ... The American journal of surgical pathology 39 (2), 141-156, 2015 | 137 | 2015 |
| Early lesions of follicular lymphoma: a genetic perspective E Mamessier, JY Song, FC Eberle, S Pack, C Drevet, B Chetaille, ... Haematologica 99 (3), 481, 2014 | 120 | 2014 |
| Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation A Garcia-Herrera, JY Song, SS Chuang, N Villamor, L Colomo, ... The American journal of surgical pathology 35 (8), 1214-1225, 2011 | 116 | 2011 |
| Positron emission tomography–directed therapy for patients with limited-stage diffuse large B-cell lymphoma: results of Intergroup National Clinical Trials Network Study S1001 DO Persky, H Li, DM Stephens, SI Park, NL Bartlett, LJ Swinnen, PM Barr, ... Journal of Clinical Oncology 38 (26), 3003, 2020 | 89 | 2020 |
| Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens A Mottok, G Wright, A Rosenwald, G Ott, C Ramsower, E Campo, ... Blood, The Journal of the American Society of Hematology 132 (22), 2401-2405, 2018 | 79 | 2018 |
| CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies H Qin, Z Dong, X Wang, WA Cheng, F Wen, W Xue, H Sun, M Walter, ... Science translational medicine 11 (511), eaaw9414, 2019 | 77 | 2019 |
| Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival G Venkataraman, JY Song, A Tzankov, S Dirnhofer, G Heinze, M Kohl, ... Blood, The Journal of the American Society of Hematology 121 (10), 1795-1804, 2013 | 76 | 2013 |
| Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets A Bouska, C Bi, W Lone, W Zhang, A Kedwaii, T Heavican, CM Lachel, ... Blood, The Journal of the American Society of Hematology 130 (16), 1819-1831, 2017 | 71 | 2017 |
| Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE MG Mei, HJ Lee, JM Palmer, R Chen, NC Tsai, L Chen, K McBride, ... Blood, The Journal of the American Society of Hematology 139 (25), 3605-3616, 2022 | 59 | 2022 |
| Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma FC Eberle, JY Song, L Xi, M Raffeld, NL Harris, WH Wilson, S Pittaluga, ... The American journal of surgical pathology 36 (5), 716-725, 2012 | 59 | 2012 |
| MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma JE Ramis-Zaldivar, B Gonzalez-Farre, A Nicolae, S Pack, G Clot, F Nadeu, ... Haematologica 106 (10), 2682, 2021 | 54 | 2021 |
| Inhibition of MDR1 overcomes resistance to brentuximab vedotin in Hodgkin lymphoma R Chen, AF Herrera, J Hou, L Chen, J Wu, Y Guo, TW Synold, VN Ngo, ... Clinical Cancer Research 26 (5), 1034-1044, 2020 | 53 | 2020 |
| SWOG S1826, a randomized study of nivolumab (N)-AVD versus brentuximab vedotin (BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL). AF Herrera, ML LeBlanc, SM Castellino, H Li, SC Rutherford, AM Evens, ... Journal of Clinical Oncology 41 (17_suppl), LBA4-LBA4, 2023 | 48 | 2023 |
| Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in … I Aldoss, T Stiller, NC Tsai, JY Song, T Cao, NA Bandara, A Salhotra, ... haematologica 103 (10), 1662, 2018 | 48 | 2018 |
| CTLA4 promotes Tyk2-STAT3–dependent B-cell oncogenicity A Herrmann, C Lahtz, T Nagao, JY Song, WC Chan, H Lee, C Yue, T Look, ... Cancer research 77 (18), 5118-5128, 2017 | 46 | 2017 |
Elaine JaffeNational Cancer InstituteDirección de correo verificada de mail.nih.gov
